Status:
UNKNOWN
Withdrawal of Colchicine in Behçet Syndrome
Lead Sponsor:
Istanbul University - Cerrahpasa
Conditions:
Behçet's Syndrome
Eligibility:
All Genders
18-65 years
Brief Summary
Behçet's syndrome is a multisystem variable vessel vasculitis. Clinical features include mucocutaneous manifestions such as oral ulcers, genital ulcers, papulopustular lesions and nodular lesions, mus...
Eligibility Criteria
Inclusion
- Fulfilling International Study Group criteria. Being between the ages of 18 and 65 years. Having mucocutaneous involvement. Using colchicine at a stable dose (1-2 mg/day) for at least 3 months. Showing no adverse events related to colchicine use. Providing informed consent to participate in the study. -
Exclusion
- Patients with active uveitis. Patients with active venous involvement. Patients with active arterial involvement. Patients with active nervous system involvement. Patients with active gastrointestinal involvement.
- \-
Key Trial Info
Start Date :
November 20 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2024
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT06146192
Start Date
November 20 2023
End Date
July 1 2024
Last Update
November 24 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.